Literature DB >> 1559102

Monoclonal antibodies in sepsis and septic shock.

D Neilson, P N Rao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1559102      PMCID： PMC1881357          DOI： 10.1136/bmj.304.6827.639-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Monoclonal antibodies in sepsis and septic shock.

Authors:  C J Hinds
Journal:  BMJ       Date:  1992-01-18

2.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

3.  Prediction of septicemia following endourological manipulation for stones in the upper urinary tract.

Authors:  P N Rao; D A Dube; N C Weightman; B A Oppenheim; J Morris
Journal:  J Urol       Date:  1991-10       Impact factor: 7.450

4.  A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.

Authors:  R L Greenman; R M Schein; M A Martin; R P Wenzel; N R MacIntyre; G Emmanuel; H Chmel; R B Kohler; M McCarthy; J Plouffe
Journal:  JAMA       Date:  1991-08-28       Impact factor: 56.272

5.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

6.  Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.

Authors:  R C Bone; C J Fisher; T P Clemmer; G J Slotman; C A Metz; R A Balk
Journal:  Crit Care Med       Date:  1989-05       Impact factor: 7.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.